Literature DB >> 23852521

Radiation oxygen biology with pulse electron paramagnetic resonance imaging in animal tumors.

Gage Redler1,2, Martyna Elas1,2,3, Boris Epel1,2, Eugene D Barth1,2, Howard J Halpern4,5.   

Abstract

The reduced oxygen in tumors (hypoxia) generates radiation resistance and limits tumor control probability (TCP) at radiation doses without significant normal tissue complication. Modern radiation therapy delivery with intensity-modulated radiation therapy (IMRT) enables complex, high-dose gradient patterns, which avoid sensitive human tissues and organs. EPR oxygen images may allow selection of more resistant parts of a tumor to which to deliver more radiation dose to enhance TCP. EPR O2 images are obtained using injected narrow-line, low relaxation rate trityl spin probes that enable pulse radiofrequency EPR O2 images of tumors in the legs of mice, rats, and rabbits, the latter exceeding 4 cm in size. Low relaxation rates of trityls have enabled novel T1-, rather than T2-, based oximetry, which provides near absolute pO2 imaging. Tomographic image formation and filtered back projection reconstruction are used to generate these images with fixed, linear stepped gradients. Images obtained both with T2 and T1 oximetric images have demonstrated the complex in vivo mechanism explaining the unexpected efficacy of TNFerade, a radiation-inducible adenoviral construct to locally produce TNF-induced vascular as well as radiation damage [1, 2]. The unexpected efficacy of large-dose radiation fractions is seen to be due to an interaction between host microvasculature and tumor cells producing a prompt (15 min) postradiation hypoxia, paralyzing tumor cell repair, and sensitizing tumors. Finally, cure of tumors treated to a single 50 % control dose shows a significant dependence on EPR O2 image hypoxic fractions, best shown with the fraction of voxels less than 10 Torr (HF10). We show that these O2 images provide a quantitative basis for measuring tumor and normal tissue response to abnormally low O2 levels. Measurements of vascular endothelial growth factor (VEGF) production in a specific syngeneic mouse fibrosarcoma, FSa versus fraction of tissue voxels with pO2 less than 10 Torr, produced a slope of 0.14 pg VEGF protein/mg total protein/% HF10. We argue that this quantification may be diagnostic of tumor versus normal tissue, and it may be etiologic in the development of malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852521      PMCID: PMC4319364          DOI: 10.1007/978-1-4614-7411-1_53

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

1.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

2.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

3.  The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia.

Authors:  Rui Kang; Tara Loux; Daolin Tang; Nicole E Schapiro; Philip Vernon; Kristen M Livesey; Alyssa Krasinskas; Michael T Lotze; Herbert J Zeh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

Review 4.  Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.

Authors:  Armando Rojas; Hector Figueroa; Erik Morales
Journal:  Carcinogenesis       Date:  2009-12-22       Impact factor: 4.944

5.  Electron paramagnetic resonance oxygen imaging of a rabbit tumor using localized spin probe delivery.

Authors:  Boris Epel; Chad R Haney; Danielle Hleihel; Craig Wardrip; Eugene D Barth; Howard J Halpern
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

6.  Characterization of response to radiation mediated gene therapy by means of multimodality imaging.

Authors:  Chad R Haney; Adrian D Parasca; Xiaobing Fan; Rebecca M Bell; Marta A Zamora; Gregory S Karczmar; Helena J Mauceri; Howard J Halpern; Ralph R Weichselbaum; Charles A Pelizzari
Journal:  Magn Reson Med       Date:  2009-08       Impact factor: 4.668

7.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

8.  A Versatile High Speed 250 MHz Pulse Imager for Biomedical Applications.

Authors:  Boris Epel; Subramanian V Sundramoorthy; Colin Mailer; Howard J Halpern
Journal:  Concepts Magn Reson Part B Magn Reson Eng       Date:  2008-07-10       Impact factor: 1.176

9.  Electron paramagnetic resonance oxygen image hypoxic fraction plus radiation dose strongly correlates with tumor cure in FSa fibrosarcomas.

Authors:  Martyna Elas; Rebecca Bell; Danielle Hleihel; Eugene D Barth; Colin McFaul; Chad R Haney; Joanna Bielanska; Katarzyna Pustelny; Kang-Hyun Ahn; Charles A Pelizzari; Masha Kocherginsky; Howard J Halpern
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-01       Impact factor: 7.038

10.  Spatial and temporal control of gene therapy using ionizing radiation.

Authors:  D E Hallahan; H J Mauceri; L P Seung; E J Dunphy; J D Wayne; N N Hanna; A Toledano; S Hellman; D W Kufe; R R Weichselbaum
Journal:  Nat Med       Date:  1995-08       Impact factor: 53.440

View more
  2 in total

1.  Rapid Scan EPR imaging as a Tool for Magnetic Field Mapping.

Authors:  Oxana Tseytlin; Andrey A Bobko; Mark Tseytlin
Journal:  Appl Magn Reson       Date:  2020-09-25       Impact factor: 0.831

2.  Heterogeneity of radiation response in mesenchymal subtype glioblastoma: molecular profiling and reactive oxygen species generation.

Authors:  Christopher P Cifarelli; Angelica Jacques; Andrey Bobko
Journal:  J Neurooncol       Date:  2021-02-10       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.